COVID-19 portal: Profiling researchers, bio-entities, and institutions

The outbreak of COVID-19 has a severe impact on our families, communities, and businesses. White House released the COVID19 literature dataset (called CORD-19 dataset) which has grown exponentially into a gigantic collection of over 500,000 articles. Researchers, practitioners, and administrators need a tool to help them digest this enormous amount of knowledge to address various scientific questions related to COVID-19. This paper showcases the COVID-19 portal to portray the research profiles of scientists, bio entities (e.g., gene, drug, disease), and institutions based on the integration of CORD-19 research literature, COVID-19 related clinical trials, PubMed knowledge graph, and the drug discovery knowledge graph. This portal provides the following profiles related to COVID-19: 1) the profile of a research scientist with his/her COVID-19 related publications and clinical trials which can be ranked by year or by the number of tweets; 2) the profile of a bio entity which could be a gene, a drug, or a disease with articles and clinical trials mentioned this bio entity; and 3) the profile of an institution with papers authored by researchers from this institution